Randomised Controlled Trial Of Two Doses Of Heparin In Cerebral Venous Thrombosis
Cerebral venous thrombosis accounts for 10-20% of strokes in the young in India. Over the past decade, heparin has become the mainstay of treatment of cerebral venous thrombosis. The conventional doses of heparin require strict monitoring of activated partial thromboplastin time. Effic...
Main Authors: | Sarma G.K, Nagaraja D |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2005-01-01
|
Series: | Annals of Indian Academy of Neurology |
Online Access: | http://www.annalsofian.org/article.asp?issn=0972-2327;year=2005;volume=8;issue=4;spage=233;epage=236;aulast=Sarma;type=0 |
Similar Items
-
Recanalisation and outcome in cerebral venous-sinus thrombosis
by: D Nagaraja
Published: (2022-01-01) -
Cerebral venous sinus thrombosis associated with SRA-negative heparin-induced thrombocytopenia: case report
by: Floyd D. Silva, et al.
Published: (2023-04-01) -
Cerebral venous thrombosis
by: Anisio Adalio de Azevedo Moraes Junior, et al.
Published: (2022-08-01) -
Cerebral venous sinus thrombosis associated with spontaneous heparin-induced thrombocytopenia syndrome after total knee arthroplasty
by: Steven R Hwang, et al.
Published: (2021-10-01) -
Pilot study examining anti-factor Xa levels for heparin monitoring and outcomes in patients with cerebral venous thrombosis
by: Yasaman Pirahanchi, et al.
Published: (2024-01-01)